Outcomes of Intrathecal Analgesia in Colorectal Surgery

Completed

Conditions studied: Surgery

In brief

Multimodal analgesia, sometimes including intrathecal analgesia (IA), is essential in any enhanced recovery pathway (ERP). This study aimed to evaluate the safety, feasibility, and optimal IA regimen in colorectal surgical patients.

Key facts

Study ID

NCT03411109

Run by

Mayo Clinic

People needed

601

Starts

2012-10-01

Expected to finish

2013-12-31

Last updated by the study team

2018-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All adult colorectal patients from October 2012 through December 2013 in which patients received single-injection IA as part of a multimodal analgesic strategy for ERP.
• Undergoing an elective colorectal operation (minimally invasive or open)

You may not qualify if…

• Patients aged < 18 years
• American Society of Anesthesiologists (ASA) 5 and 6 classification
• pregnancy
• failure to provide research authorization.
• emergent operations

Where it is running

• Mayo Clinic — Jacksonville, Florida, United States
• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.